← Back to Search

Telehealth-enhanced Hybrid CR for Acute Coronary Syndrome

N/A

Waitlist Available

Led By Andrea T Duran, PhD

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and 3-month post program completion

Awards & highlights

Study Summary

This trial will compare the effects of telehealth-enhanced hybrid cardiac rehabilitation (THCR) versus traditional cardiac rehabilitation (CR) on ACS survivors.

Eligible Conditions

Acute Coronary Syndrome
Heart Attack

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and 3-month post program completion

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and 3-month post program completion

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 3-month post program completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mean proportion of CR sessions completed by participants allocated to the THCR intervention

Number of participants who are successfully enrolled into the pilot study per month

Secondary outcome measures

Mean proportion of CR sessions completed by those allocated to the traditional CR intervention

Proportion of participants that attend ≥1 CR session after randomization in each arm

Proportion of participants who report adequate feasibility of the THCR intervention

Other outcome measures

Change in health-related quality of life score

Change in total distance traveled in 6MWT

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Telehealth-enhanced Hybrid CRExperimental Treatment1 Intervention

Participants will receive a hybrid version of cardiac rehabilitation.

Group II: Traditional CRActive Control1 Intervention

Participants will receive a standard of care version of cardiac rehabilitation.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Center for Advancing Translational Sciences (NCATS)NIH

320 Previous Clinical Trials

401,690 Total Patients Enrolled

National Institutes of Health (NIH)NIH

2,696 Previous Clinical Trials

6,952,539 Total Patients Enrolled

2 Trials studying Acute Coronary Syndrome

440 Patients Enrolled for Acute Coronary Syndrome

Columbia UniversityLead Sponsor

1,431 Previous Clinical Trials

2,460,793 Total Patients Enrolled

9 Trials studying Acute Coronary Syndrome

3,711 Patients Enrolled for Acute Coronary Syndrome

Media Library

Telehealth-enhanced Hybrid CR Clinical Trial Eligibility Overview. Trial Name: NCT05328375 — N/A

Acute Coronary Syndrome Research Study Groups: Traditional CR, Telehealth-enhanced Hybrid CR

Acute Coronary Syndrome Clinical Trial 2023: Telehealth-enhanced Hybrid CR Highlights & Side Effects. Trial Name: NCT05328375 — N/A

Telehealth-enhanced Hybrid CR 2023 Treatment Timeline for Medical Study. Trial Name: NCT05328375 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the scope of enrollment for this clinical research study?

"Affirmative. The information found at clinicaltrials.gov verifies that this trial is still open to new participants, having been first published on March 11th 2022 and last updated in May 4th 2022. 40 individuals are needed from 1 location for the study's completion."

Answered by AI

Are investigators currently enrolling participants in this investigation?

"The information on clinicaltrials.gov reveals that this scientific endeavor is actively recruiting volunteers. It was originally launched on March 11th 2022 and the latest update to its profile occurred on May 4th 2022."

Answered by AI